Literature DB >> 30391470

What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.

John W Ward1, Alan R Hinman2.   

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) cause 1.3 million deaths annually. To prevent more than 7 million deaths by 2030, the World Health Organization set goals to eliminate HBV and HCV, defined as a 90% reduction in new infections and a 65% reduction in deaths, and prevent more than 7 million related deaths by 2030. Elimination of HBV and HCV is feasible because of characteristics of the viruses, reliable diagnostic tools, and available cost-effective or cost-saving interventions. Broad implementation of infant immunization against HBV, blood safety, and infection-control programs have greatly reduced the burden of HBV and HCV infections. To achieve elimination, priorities include implementation of HBV vaccine-based strategies to prevent perinatal transmission, safe injection practices and HCV treatment for persons who inject drugs, and testing and treatment for HBV- and HCV-infected persons. With sufficient capacity, HBV and HCV elimination programs can meet their goals.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eradication; Health Disparities; Injection Drug Use; Liver Cancer

Mesh:

Year:  2018        PMID: 30391470     DOI: 10.1053/j.gastro.2018.10.048

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

1.  When viruses collide: hepatitis B virus reactivation after hepatitis C treatment.

Authors:  Ashwin Balagopal; Chloe L Thio
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

2.  Hepatitis B and C in Pakistan: A community survey.

Authors:  Nismat Javed; Muhammad Hassan Nadeem; Haider Ghazanfar
Journal:  Cureus       Date:  2019-10-24

Review 3.  Pre-Exposure Prophylaxis for viral infections other than HIV.

Authors:  Vicente Soriano; Ana Treviño; Carmen de Mendoza; Víctor Moreno-Torres; Ilduara Pintos; Pablo Barreiro; Octavio Corral
Journal:  Infez Med       Date:  2022-09-01

4.  Retrospective Evaluation of Hepatitis C Awareness in Turkey Through Two Decades.

Authors:  Hatice Yasemin Balaban; Osman Dağ; Alparslan Alp; Nomingerel Tseveldorj; Cavanşir Vahabov; Mehmet Akif Göktaş; Tuğrul Pürnak; Gülşen Hasçelik; Hülya Demir; Bülent Sivri; Halis Şimşek
Journal:  Turk J Gastroenterol       Date:  2021-01       Impact factor: 1.852

Review 5.  The cGAS-STING Pathway: Novel Perspectives in Liver Diseases.

Authors:  Dongwei Xu; Yizhu Tian; Qiang Xia; Bibo Ke
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 8.786

6.  Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium.

Authors:  Özgür M Koc; Cécile Kremer; Niel Hens; Rob Bielen; Dana Busschots; Pierre Van Damme; Geert Robaeys
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

Review 7.  HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications.

Authors:  Carolina Boni; Valeria Barili; Greta Acerbi; Marzia Rossi; Andrea Vecchi; Diletta Laccabue; Amalia Penna; Gabriele Missale; Carlo Ferrari; Paola Fisicaro
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

8.  Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus Assembly.

Authors:  Adam Rolt; Daniel C Talley; Seung Bum Park; Zongyi Hu; Andrés Dulcey; Christopher Ma; Parker Irvin; Madeleine Leek; Amy Q Wang; Andrew V Stachulski; Xin Xu; Noel Southall; Marc Ferrer; T Jake Liang; Juan J Marugan
Journal:  J Med Chem       Date:  2021-06-29       Impact factor: 7.446

Review 9.  A Focused Review on Recent Advances in the Diagnosis and Treatment of Viral Hepatitis.

Authors:  Wei Zhang; Mahmoud Aryan; Steve Qian; Roniel Cabrera; Xiuli Liu
Journal:  Gastroenterology Res       Date:  2021-06-19

Review 10.  Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination.

Authors:  Fátima Higuera-de la Tijera; Alfredo Servín-Caamaño; Luis Servín-Abad
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.